How were IMARA's earnings last quarter?

IMARA Inc. (NASDAQ:IMRA) released its earnings results on Tuesday, November, 9th. The company reported ($2.20) EPS for the quarter, topping the consensus estimate of ($3.64) by $1.44. During the same quarter last year, the firm posted ($2.88) earnings per share.

When did IMARA's stock split?

IMARA's stock reverse split on Friday, February 24th 2023. The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of IMARA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMARA investors own include Novavax (NVAX) , Axsome Therapeutics (AXSM) , OPKO Health (OPK) , BioXcel Therapeutics (BTAI) , Johnson & Johnson (JNJ) , Bristol-Myers Squibb (BMY) , Dynavax Technologies (DVAX) , Micron Technology (MU) , Provention Bio (PRVB) and Abbott Laboratories (ABT) .

IMARA (IMRA) raised $76 million in an initial public offering on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO.

NASDAQ:IMRA

IMARA (IMRA) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free IMRA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $6.32
▼
$25.28
52-Week Range: N/A

Volume: 271,700 shs
Average Volume: 138,364 shs
Market Capitalization: $165.80 million

P/E Ratio: 126.40
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get IMARA alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About IMARA Stock (NASDAQ:IMRA)

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

IMRA Stock News Headlines

August 23, 2023 | health.usnews.com

Imara Blume

March 3, 2023 | finance.yahoo.com

IMARA Inc. (IMRA) Stock Historical Prices & Data - Yahoo Finance

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 22, 2023 | finance.yahoo.com

Imara Announces Stockholder Approval of Merger With Enliven

January 5, 2023 | benzinga.com

SHAREHOLDER ALERT: Weiss Law Reminds IMRA, TIG, FORG, and BRBW Shareholders About Its Ongoing Investigations

October 25, 2022 | benzinga.com

Imara 10% Owner Trades $336K In Company Stock

October 20, 2022 | benzinga.com

$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying - Imara - Benzinga

October 18, 2022 | prnewswire.com

STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of IMARA Inc. - IMRA - PR Newswire

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

October 18, 2022 | prnewswire.com

STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of IMARA Inc. - IMRA

October 17, 2022 | streetinsider.com

AHF to Protest CIGNA for Shortchanging Pharmacies: 'Cigna Doesn't Care!' - StreetInsider.com

October 17, 2022 | bloomberg.com

Zimbabwe's Currency Crackdown Spurs Wider Use of US Dollars - Bloomberg

October 17, 2022 | bizjournals.com

Struggling blood disorder biotech Imara shuts down via reverse merger - Boston Business Journal - The Business Journals

October 17, 2022 | benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session - Applied DNA Sciences (NASDAQ:APDN), Acorda - Benzinga

October 16, 2022 | benzinga.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, FCRD, IMRA - Imara (NASDAQ:IMRA), First Ea - Benzinga

October 15, 2022 | benzinga.com

Lifshitz Law PLLC Announces Investigations of OIIM, JVA, SLDB, and IMRA - Imara (NASDAQ:IMRA), Coffee Hol - Benzinga

October 15, 2022 | benzinga.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, IMRA, SBTX - Imara (NASDAQ:IMRA), LogicBio - Benzinga

October 14, 2022 | benzinga.com

How Is The Market Feeling About Imara? - Imara (NASDAQ:IMRA) - Benzinga

October 14, 2022 | morningstar.co.uk

Arix Bioscience says Imara to merge with Enliven Therapeutics - Morningstar

October 14, 2022 | prnewswire.com

Thinking about buying stock in Imara, Nutanix, Azul, 22nd Century Group, or Altimmune? - PR Newswire

October 14, 2022 | benzinga.com

Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket - Black Diamond Ther - Benzinga

October 14, 2022 | marketscreener.com

IMARA INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

October 13, 2022 | ca.investing.com

Dow Futures Tick Higher After Indices Stage Major Reversal By Investing.com - Investing.com Canada

October 13, 2022 | seekingalpha.com

Cancer drug developer Enliven Therapeutics and Imara to merge in all-stock deal - Seeking Alpha

October 13, 2022 | streetinsider.com

Form 8-K IMARA Inc. For: Oct 13 - StreetInsider.com

October 13, 2022 | marketwatch.com

Imara, Enliven Therapeutics Agree to Merge in All-Stock Deal - MarketWatch

October 13, 2022 | businesswire.com

IMRA Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Imara Inc. is Fair to Shareholders - Business Wire

See More Headlines

Receive IMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/09/2021
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:IMRA
CUSIP: N/A
CIK: 1672619
Web: www.imaratx.com
Phone: N/A
Fax: N/A
Employees: 41
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.05
Trailing P/E Ratio: 126.40
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $1.49 million
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: 2.12%
Return on Assets: 2.00%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 48.98
Quick Ratio: 48.98

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: 75.24
Book Value: $3.44 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 26,234,000
Free Float: 16,449,000
Market Cap: $165.80 million
Optionable: Not Optionable
Beta: 1.09

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. Rahul D. Ballal Ph.D. (Age 44)
Pres, CEO & Director
Comp: $761.55k
Mr. Michael P. Gray MBA (Age 51)
CPA, CFO & COO
Comp: $641.24k
Mr. Stephen M. Migausky J.D.
Sr. VP of Legal & Gen. Counsel

Key Competitors

View All Competitors

IMRA Stock Analysis - Frequently Asked Questions

How were IMARA's earnings last quarter?: IMARA Inc. (NASDAQ:IMRA) released its earnings results on Tuesday, November, 9th. The company reported ($2.20) EPS for the quarter, topping the consensus estimate of ($3.64) by $1.44. During the same quarter last year, the firm posted ($2.88) earnings per share.
When did IMARA's stock split?: IMARA's stock reverse split on Friday, February 24th 2023. The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.
What other stocks do shareholders of IMARA own?: Based on aggregate information from My MarketBeat watchlists, some companies that other IMARA investors own include Novavax (NVAX), Axsome Therapeutics (AXSM), OPKO Health (OPK), BioXcel Therapeutics (BTAI), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Dynavax Technologies (DVAX), Micron Technology (MU), Provention Bio (PRVB) and Abbott Laboratories (ABT).
When did IMARA IPO?: IMARA (IMRA) raised $76 million in an initial public offering on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO.

This page (NASDAQ:IMRA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

IMARA (IMRA) Stock Price, News & Analysis

About IMARA Stock (NASDAQ:IMRA)

IMRA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

IMRA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info